Home Subscription Services
 
   

 
Journal of Oral & Facial Pain and Headache
OFPH Home Page
About the Editor
Editorial Board
Accepted Manuscripts
Submit
Author Guidelines
Submission Form
Reprints / Articles
Permissions
Advertising
MEDLINE Search
 
 
 
 
 
FacebookTwitter
Quintessence Publishing: Journals: OFPH
Journal of Oral & Facial Pain and Headache

Edited by Barry J. Sessle, BDS, MDS, BSc, PhD, FRSC

Official Journal of the American Academy of Orofacial Pain,
the European, Asian, and Ibero-Latin Academies of Craniomandibular
Disorders, and the Australian Academy of Orofacial Pain

ISSN 2333-0384 (print) • ISSN 2333-0376 (online)

Publication:
Summer 2005
Volume 19 , Issue 3

Back
Share Abstract:

A New Analyzing Method for Quantification of Abrasion on the Bruxcore Device for Sleep Bruxism Diagnosis

Michelle A. Ommerborn, Dr Med Dent/Maria Giraki, DDS/Christine Schneider, PhD/Ralf Schaefer, PhD/Andreas Gotter, BSME/Matthias Franz, MD/Wolfgang H.-M. Raab, Dr Med Dent

Pages: 232238
PMID: 16106717

Aims: To evaluate a newly developed semi-automatic computer-based method to analyze the objectivity of the Bruxcore Bruxism-Monitoring Device (BBMD) by assessing the interrater reliability. The capability of the BBMD to differentiate between sleep bruxers (SB) and healthy controls was also verified by estimating the sensitivity, specificity, and predictive values. Methods: Forty-eight SB and 21 controls took part in this investigation. After a detailed clinical dental examination, each participant received a BBMD to be worn for 5 consecutive nights. The BBMDs were then scanned and rated by 2 independent examiners using the new method, which counted the abraded area in pixels. Interrater reliability was assessed by intraclass correlation coefficient (ICC) analyses. Results: The analyses showed a very high interrater reliability of ICC = 0.99, and comparison of the mean pixel scores revealed values that were approximately 8 times higher for the SB than for the controls. With a selected pixel score cutoff point of 2900, a sensitivity of 79.2% and a specificity of 95.2% were found. The clinical diagnosis was correctly predicted in 97.4% of the SB and 66.7% of the controls. Conclusion: The results support the assumption that the newly developed analyzing method for the assessment of the BBMD is a clinically suitable, objective, and applicable method that seems to be able to differentiate between SB and a healthy control sample. These data, however, need to be confirmed in further investigations using polysomnographic recordings. J Orofac Pain 2005;19:232238

Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
  © 2014 Quintessence Publishing Co Inc
 

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog